CJC-1295 (DAC) vs Sermorelin
Compare the research, key figures and safety notes.
How they differ
Both nudge the body to release its own growth hormone the same way, but they last very different amounts of time. Sermorelin is gone in about ten minutes, so it's taken nightly as a quick pulse. CJC-1295 with DAC grabs onto a blood protein and lasts about a week, so it's taken weekly and holds a steady level. Both have been tested in people — sermorelin was once a licensed product, and the DAC form comes from a step-up dosing study.
Side by side
| Measure | CJC-1295 (DAC) | Sermorelin |
|---|---|---|
| Category | Growth hormone axis | Growth hormone axis |
| Evidence | A · Human dose research | A · Human dose research |
| Route | Subcutaneous | Subcutaneous |
| Half-life | 168 h | 0.2 h |
| Typical vial | 2 / 5 mg | 5 / 9 mg |
| Research amount | 2–4 mg | 100–500 mcg |
| Common schedule | Once a week | Every day |
| Cycle / break | 8–12 / 4 | 8–12 / 4 |
| Studied for | Growth-hormone release | Growth-hormone release |
These amounts and schedules are figures discussed in research and community reports, shared for learning — not a recommendation and not medical advice. A step-by-step dosing schedule exists only where a human trial backs it; the evidence tier tells you which.
Decay curves, overlaid
Each line is scaled to that compound's own first dose, so the chart shows how each one builds up over time — not how the compounds' doses compare to one another, which these different molecules share no common unit for.
How they combine
Educational reference on commonly-discussed combinations, not medical advice. Combining compounds can change how each behaves — read this as a prompt to research, not a clearance.